Evaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Viol… (NCT06176300) | Clinical Trial Compass
By InvitationNot Applicable
Evaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence
United States3,390 participantsStarted 2022-02-16
Plain-language summary
The goal of this research study is to implement and evaluate a comprehensive community-level approach, Healthy Communities for Youth, that includes both a selective hospital-based prevention strategy, Emerging Leaders, and universal prevention strategies that increase Positive Youth Development opportunities through participatory action research, stakeholder education, community mobilization, and an overall focus on increasing community capacity for prevention. Key project aims are to evaluate the impact of Healthy Communities for Youth on community rates of youth violence using surveillance data and evaluate the impact of each violence prevention strategy on proximal outcomes including their impact on risk factors and protective processes related to multiple forms of youth violence.
Who can participate
Age range
12 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
PAR-SEED Method:
Inclusion criteria:
* Community residents, youth aged 12-17 and parents, living in one of the intervention communities (Community A and Community B)
* Stakeholders who reside or work in one of the intervention communities (Community A and Community B) or who contribute other expertise
* Be able to consent/assent
Exlcusion criteria:
* Those who do not meet the inclusion criteria
* Those with limited English proficiency
Emerging Leaders:
Inclusion criteria:
* Violently injured or high-risk youth that have either received or are receiving treatment or had a family member or relative receive treatment at VCU Health, or who live in one of the intervention communities, or have been referred by a community partner.
* Aged 14 through 24
* Reside in one of the two intervention communities (Community A and Community B) or in the control community (Community C)
* Be able to consent/assent
Exclusion criteria:
* Youth younger than 14 and older than 24 will be excluded.
* Prisoners will be excluded.
* Those living outside our community boundaries will be excluded.
PAR/Youth Voices:
Inclusion criteria:
* Youth in grades 9 through 12
* Reside in one of the intervention communities (Community A and Community B) and attend the designated high school(s) serving that community (Community A or Community B)
* Be able to consent/assent
Exclusion criteria:
* Youth in grades below 9th
* Youth who have graduated from high school
* Youth recruited for School A, cannot res…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.